December 15, 2021
14:00 – 15:30
End of year COVID-19 vaccine manufacturing update and challenges for 2022
The Biotechnology Innovation Organization (BIO), the Developing Countries Vaccine Manufacturers Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) are all COVID-19 vaccine manufacturers partners of COVAX. The press briefing, hosted by IFPMA, will take stock of the progress achieved in developing and scaling up COVID-19 vaccines production, and address the challenges that need to be tackled to achieve equitable access to COVID-19 vaccines.
- Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- Dr Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organization (BIO)
- Sai Prasad, Executive Director, Quality Operations, Bharat Biotech, and President, Developing Countries Vaccine Manufacturers Network (DCVMN)
With the introduction of data by Rasmus Bech Hansen, CEO & Founder, Airfinity.
Click here to see the full press release
Watch again on YouTube: https://youtu.be/rnImrulpFoM